查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年載玻片染色機的全球市場
市場調查報告書
商品編碼
1166511

2022-2029 年載玻片染色機的全球市場

Global Slide Stainer Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

到 2021 年，載玻片染色機的全球市場規模將達到 37.042 億美元，並且在預測期間（2022-2029 年）的複合年增長率為 11%。

染色劑用於分離組織和細胞以進行顯微鏡檢查和鑑定。 載玻片染色機通過直接染色、間接染色、表面吸附染色和媒染染色將染料擴散到標本中，從而自動對製備好的細胞學和組織學標本進行染色。 全自動染色機有旋轉輸送和直線輸送兩種工藝。

市場動態

全球載玻片染色機市場的增長受到慢性病和傳染病患病率上升的推動，技術進步以及對診斷和臨床研究自動化需求的增長是推動市場增長的關鍵因素。

慢性病患病率上升預計將推動預測期內的增長

慢性和危及生命的疾病數量不斷增加，這促使製藥和研究公司將研發工作重點放在開發有效的治療方法上。 實驗室儀器自動化的進步導致載玻片染色機被應用於疾病診斷和腫瘤研究。

根據國際糖尿病聯合會的數據，2019 年糖尿病患者花費了 7600 億美元，其中大部分花在了 1 型糖尿病患者的胰島素上。 目前，約有 4.63 億成年人（20-79 歲）患有糖尿病，預計到 2045 年將增加到 7 億。 在大多數國家，2 型糖尿病患者的比例都在增加。 此外，據美國心臟協會稱，2015 年約有 41.5% 的美國人口患有某種形式的心髒病，預計到 2035 年這一患病率將增加到 45%。 根據美國疾病控制和預防中心 (CDC) 的數據，大約一半 (47%) 的美國人口至少具有這三種風險因素中的一種。 根據美國國家癌症研究所的數據，最常見的癌症是前列腺癌、乳腺癌、肺癌和支氣管癌、結直腸癌、皮膚黑色素瘤、膀胱癌、非霍奇金淋巴瘤、腎癌和腎盂癌、子宮內膜癌、白血病、胰腺癌、甲狀腺癌和肝癌。

因此，慢性病和傳染病引起的日益嚴重的健康危害是推動載玻片染色機需求的主要因素，尤其是在發達國家。 在新興國家，傳染病的流行正在增加常規體檢的公共支出，促使醫院和其他醫療保健提供者實現實驗室流程自動化。 因此，對高性能載玻片染色機的需求正在增加。

與自動載玻片染色機相關的擔憂可能會阻礙市場增長

使用自動染色機存在一些問題，例如初始成本、空間可用性和維修問題，這些問題減緩了載玻片染色機的採用。 常規染色機可能只有手動方法作為備用，或者染色機可能佔據實驗室中唯一適合手動染色系統的空間。

對於發展中國家缺乏專業知識的服務技術人員來說，停機維修時間更長。 一些工程師反對僅限於某些系統所需的專有試劑。

另一個問題是實驗室技術人員離開了染色過程。 手工染色時，技術人員可以觀察每個步驟。 如果您覺得有什麼地方不對勁，您通常可以停止程序並解決問題。

自動化系統中的染色問題在此階段很難排除，因為在看到成品之前可能不會注意到染色問題。 在培訓環境中，學習染色原理很重要，但用機器代替人眼和手可能會損害您理解實際染色過程的能力。

行業分析

全球載玻片染色機市場根據波特五力分析、供應鏈分析、監管分析、定價分析、報銷分析和未滿足需求等各種行業因素對市場進行了深入分析。

COVID-19 影響分析

COVID-19 大流行每天都在繼續蔓延，嚴重影響著人們、社區和企業。 在對某些行業的增長產生重大影響的同時，許多其他市場可能保持完好並提供有希望的增長機會。 全球載玻片染色機市場從 COVID-19 流行病中看到了巨大的推動力，因為利益相關者越來越多地尋找診斷和治療感染 COVID-19 患者的新方法。

一些製藥和生物技術公司正在加大研發力度。 因此，預計對臨床研究的需求增加將為載玻片染色機製造商帶來一些機會，從而有望在預測期內推動市場增長。 新型冠狀病毒的急劇爆發正在影響全球的生活。 醫院和實驗室需要獲得可靠的 COVID-19 測試套件，並且已經出現了幾家公司來幫助一線醫療專業人員抗擊 COVID-19 的傳播。 診斷或分子測試可以回答一個人是否感染了活躍的 SARS-CoV-2。 另一方面，血清學和抗體測試通過在一個人的血液中尋找 COVID-19 抗體來揭示一個人是否感染了 COVID-19。 超過 100 項 COVID-19 診斷測試已獲得緊急使用授權 (EUA)。

內容

第 1 章載玻片染色機的研究方法和全球市場範圍

  • 調查方法
  • 調查目的和範圍

第 2 章全球載玻片染色機市場：市場定義和概述

第 3 章全球載玻片染色機市場：執行摘要

  • 按產品細分的市場
  • 按技術劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章全球載玻片染色機市場：市場動態

  • 市場影響因素
    • 司機
      • 慢性病發病率增加
      • 實驗室自動化的進步
    • 約束因素
      • 與寡核甘酸治療相關的監管問題。
      • 缺乏具備知識和技能的工程師
    • 商機
    • 影響分析

第 5 章全球載玻片染色機市場：行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 報銷分析
  • 未滿足的需求

第 6 章全球載玻片染色機市場：COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章全球載玻片染色機市場：按產品分類

    • 試劑
    • 設備
      • 自動載玻片染色機
      • 手動載玻片染色套裝
    • 耗材/配件

第 8 章全球載玻片染色機市場：按技術分類

  • 免疫組織化學
  • 細胞學
  • 血液學
  • 蘇木精和曙紅
  • 原位雜交
  • 微生物學
  • 特殊染色

第 9 章全球載玻片染色機市場：按最終用戶分類

  • 醫院
  • 診斷中心
  • 製藥公司、生物技術公司
  • 學術和研究機構
  • 其他

第 10 章全球載玻片染色機市場：按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章全球載玻片染色機市場：競爭格局

  • 競爭場景
  • 市場分析/市場份額分析
  • 併購分析

第 12 章載玻片染色機的全球市場：公司簡介

  • Agilent Technologies Inc.
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Biogenex
  • Merck Group
  • Sakura Finetechnical
  • Elitechgroup
  • Biocare Medical
  • Hardy Diagnostics

第13章 載玻片染色機的全球市場：DataM

簡介目錄
Product Code: DMLE2650

Market Overview

The global slide stainer market size was valued at US$ 3704.2 million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 11% during the forecast period (2022-2029).

A stainer is used to separate tissues or cells, to carry microscopic study and identification. A slide stainer automates the staining of prepared cytology or histology tissue specimens by diffusing dyes into the samples through direct or indirect staining, surface adsorption, or mordant staining. An automated slide stainer uses two processes, rotating transport and linear transport.

Market Dynamics

The global slide stainer market growth is driven rising prevalence of chronic and infectious diseases, technological advancements, and growing demand for automation in diagnostics and clinical research are among the key factors driving the market growth.

The increasing prevalence of chronic diseases is expected to drive growth in the forecast period

The growing prevalence of chronic and life-threatening diseases is driving pharmaceutical companies and research firms to focus on R&D activities to develop effective therapeutics. Strides made in lab instrumentation automation have led to the application of slide stainers in disease diagnosis and oncology research.

As per the International Diabetes Federation, diabetes patients spent US$ 760 billion in 2019, of which, most was spent by Type-1 diabetes patients on insulin drugs. Around 463 million adults (20-79 years) are living with diabetes currently, and by 2045 this is projected to rise to 700 million. The proportion of type 2 diabetes people is increasing in most countries. Also, as per the American Heart Association, in 2015, approximately 41.5% of the U.S. population was suffering from some form of cardiac disease, it is further estimated that this prevalence is likely to increase to 45% by 2035. According to the Centers for Disease Control and Prevention (CDC) of the U.S., about half of the population (47%) of the United States have at least one of these three risk factors. According to the National Cancer Institute, the most common cancers are prostate cancer, breast cancer, lung and bronchus cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer.

Hence, the growing health burden of chronic and infectious diseases is a major factor boosting the demand for slide stainers, especially in developed countries. In developing countries, the prevalence of infectious diseases has increased the spending of the population on regular health checkups, which has encouraged healthcare providers such as hospitals to automate lab processes. This has increased the demand for high-performing slide stainers.

Concerns associated with automated slide stainers are likely to hinder market growth

There are some concerns associated with the use of autostainers such as the initial expense, space availability, and repair issues, which are slow the adoption of slide stainers. A routine stainer may have only a manual method as a backup, but the stainer may be occupying the only space in the laboratory where a manual stain system can fit.

The downtime for repairs is lengthy if service technicians with lack of professional technicians in developing countries. Some technologists object to being limited to the dedicated reagents required by some systems.

Another concern is that the technologist is now removed from the staining process. When doing a manual stain, the technologist can observe each step; if he or she sees that something is wrong, the procedure can often be stopped to correct the problem.

A staining problem on an automated system may not be noticed until the finished product is reviewed, and sometimes troubleshooting at this stage is difficult. In training situations, learning the principles of staining is important, and the use of a machine instead of human eyes and hands may impair the trainee's ability to understand the actual process of staining.

Industry Analysis

The global slide stainer market provides in-depth analysis of the market based on various industry factors such as porter's five force analysis, supply chain analysis, regulatory analysis, pricing analysis, reimbursement analysis, unmet needs.

COVID-19 Impact Analysis

The COVID-19 pandemic continues to unfold everyday with severe impact on people, communities, and businesses. The growth in several industries are impacted significantly while numerous other markets may remain unscathed and show promising growth opportunities. The global slide stainer market has received immense impetus from the COVID-19 pandemic, as stakeholders are increasingly searching for newer approaches towards diagnosing and curing patients affected by the COVID-19.

Increasing research and development is being undertaken by several pharmaceutical and biotechnology companies. Thus, rising demand for clinical research is expected to generate several opportunities for the slide stainer manufacturers, hence, expected to boost the market growth over the forecast period. The dramatic explosion of the novel coronavirus is affecting lives globally. Hospitals and labs need access to reliable COVID-19 test kits, and several companies are coming up to support the medical professionals on the front lines working to prevent the spread of COVID-19. Diagnostic or molecular tests answer whether a person has active SARS-CoV-2 infection or not. In contrast, serological or antibody tests reveal if a person had COVID-19 by assaying for the presence of antibodies to COVID-19 in a person's blood. Over 100 COVID-19 diagnostic tests with Emergency Use Authorization (EUA).

Segment Analysis

The hematoxylin and eosin segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

Hematoxylin and Eosin have been used for recognizing various tissue types and morphologic changes. Hematoxylin has deep blue to purple color and stain nuclei of the cells, against pink background counterstained by Eosin. Moreover, hematoxylin and eosin are the key ingredients in stains used by biological laboratories and pathologists. Hematoxylin is an excellent nuclear stain that is used widely in cytology and histology, two of the most important uses being as a nuclear stain in the Papanicolaou procedure for the diagnosis of vaginal cancer and in combination with the contrast stain Eosin, which is the chief diagnostic tool for most other cancers.

Rising demand for the hematoxylin and eosin for the various diagnostic test and laboratories uses is expected to fuel the growth of the segment over the forecast period. Moreover, increasing technological development such as the expansion of high throughput hematology analyzers and the introduction of basic cytometry techniques analyzers have been propelling segment growth and the trend is expected to continue over the forecast period.

However, intense competition among existing players and the high cost of hematoxylin and eosin are supposed to restrain the market in the forecast period. Also, time-consuming and stringent regulatory policies are projected to hamper market growth over the forecast period.

Geographical Analysis

North America region holds the largest market share of the global slide stainer market

North America is anticipated to account for a major share of the global slide stainer market. This can be ascribed to the region leading in a wide array of diagnostic and research capabilities and in the adoption of automation for the same. Histological and cytological examinations are a routine part of diagnostics and drug discovery research, an arena in which North America are frontrunners. Key players operating in the global slide stainer market in the region are collaborating, partnership, acquisition and product launch, that will drive the growth of the market in the region.

For instance, in February 13, 2020, Biocare Medical LLC Launch of seven novel IVD IHC antibody markers for clinical diagnostics and research applications. The most recent launch focuses on several immuno-oncology markers, critical in aiding early-stage cancer drug developments and patient treatment.

Also, in the USA, favorable national regulatory mechanisms along with presence of large patient pool further accelerates overall business growth. Moreover, increasing use of dignostic services with enhanced support for research and ethics augments the demand for slide stainer in the region.

Competitive Landscape

The slide stainer market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Agilent Technologies Inc., Danaher Corp., Sakura, BioGenex, Thermo Fisher Scientific, Biocare Medical, Merck Group, General Data Company, and Hardy Diagnostics, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the slide stainer market globally. For instance, in March 2020, ELITechGroup Inc. launched the Aerospray Cytology Slide Stainer Cytocentrifuge which automates the preparation and staining of liquid-based cytology specimens to facilitate the examination of an array of cell differentiations utilizing Papanicolaou staining techniques. The device performs two functions of sample preparation through cytocentrifugation and sample staining.

Key Companies to Watch

Sakura Finetek

Overview: Sakura Finetek, was founded in 1986 with the U.S. office based in Torrance, California. It is the global leader in continuous innovation for pathology by providing integrated solutions for anatomic pathology and patients through best-in-class innovation, quality, and customer care. Sakura Finetek is a leading industry in the development and commercialization of automated histology instrumentation and consumables for anatomic pathology. The company specializes in pathology, histology, smart automation, tissue processors, tissue embedders, H&E stainers, cover slippers - film & glass, advanced staining - IHC & ISH, microtomes, cassette & slide printers, blades, grossing, storage systems - blocks & slides, cryostats, digital microscopes, histopathology, cancer diagnostics, tissue-Tek, accu-edge, and histology consumables

Product Portfolio: Histo-Tek SL Slide Stainer: The Histo-Tek SL Slide Stainer is an automated slide stainer offering a new level of convenience and standardization for your low-volume laboratory needs, all at a low total cost of ownership.

The global slide stainer market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages.

Table of Contents

1. Global Slide Stainer Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Slide Stainer Market - Market Definition and Overview

3. Global Slide Stainer Market - Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Technology
  • 3.3. Market Snippet by End-User
  • 3.4. Market Snippet by Region

4. Global Slide Stainer Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing incidence of chronic diseases
      • 4.1.1.2. Increasing automation in laboratories
      • 4.1.1.3. XX
    • 4.1.2. Restraints:
      • 4.1.2.1. Regulatory issues associated with oligonucleotide therapeutics,
      • 4.1.2.2. Lack of knowledgeable and skilled technicians
      • 4.1.2.3. XX
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Slide Stainer Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. Global Slide Stainer Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Slide Stainer Market - By Product

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
  • 7.3. Market Attractiveness Index, By Product Segment
    • 7.3.1. Reagents *
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Equipment
      • 7.3.2.1. Automated Slide Stainers
      • 7.3.2.2. Manual Slide Staining Sets
    • 7.3.3. Consumables & Accessories

8. Global Slide Stainer Market - By Technology

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 8.3. Market Attractiveness Index, By Application Segment
    • 8.3.1. Immunohistochemistry*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Cytology
    • 8.3.3. Hematology
    • 8.3.4. Hematoxylin and Eosin
    • 8.3.5. In Situ Hybridization
    • 8.3.6. Microbiology
    • 8.3.7. Special Stains

9. Global Slide Stainer Market - By End-User

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 9.3. Market Attractiveness Index, By End-User Segment
    • 9.3.1. Hospitals*
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Diagnostic Centers
    • 9.3.3. Pharmaceutical and Biotechnology Companies
    • 9.3.4. Academic and Research Institutes
    • 9.3.5. Others

10. Global Slide Stainer Market - By Region

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 10.3. Market Attractiveness Index, By Region
  • 10.4. North America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. U.S.
      • 10.4.6.2. Canada
      • 10.4.6.3. Mexico
  • 10.5. Europe
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. Germany
      • 10.5.6.2. U.K.
      • 10.5.6.3. France
      • 10.5.6.4. Italy
      • 10.5.6.5. Spain
      • 10.5.6.6. Rest of Europe
  • 10.6. South America
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.6.6.1. Brazil
      • 10.6.6.2. Argentina
      • 10.6.6.3. Rest of South America
  • 10.7. Asia Pacific
    • 10.7.1. Introduction
    • 10.7.2. Key Region-Specific Dynamics
    • 10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.7.6.1. China
      • 10.7.6.2. India
      • 10.7.6.3. Japan
      • 10.7.6.4. Australia
      • 10.7.6.5. Rest of Asia Pacific
  • 10.8. Middle East and Africa
    • 10.8.1. Introduction
    • 10.8.2. Key Region-Specific Dynamics
    • 10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

11. Global Slide Stainer Market - Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Global Slide Stainer Market- Company Profiles

  • 12.1. Agilent Technologies Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. F. Hoffmann-La Roche Ltd.
  • 12.3. Thermo Fisher Scientific
  • 12.4. Danaher Corporation
  • 12.5. Biogenex
  • 12.6. Merck Group
  • 12.7. Sakura Finetechnical
  • 12.8. Elitechgroup
  • 12.9. Biocare Medical
  • 12.10. Hardy Diagnostics

LIST NOT EXHAUSTIVE

13. Global Slide Stainer Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us